Intensity-modulated radiotherapy vs. conventional radiotherapy in the treatment of anal squamous cell carcinoma: A propensity score analysis

Radiotherapy and Oncology

Volumn 107, Issue 2, 2013, Pages 189-194

  Dasgupta, Tina ^a,b   Rothenstein, Diana ^b   Chou, Joanne F ^b   Zhang, Zhigang ^b   Wright, Jean L ^b,c   Saltz, Leonard B ^d   Temple, Larissa K ^b   Paty, Philip B ^b   Weiser, Martin R ^b   Guillem, Jose G ^b   Nash, Garrett M ^b   Goodman, Karyn A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d Department of Gastrointestinal Oncology ^*  (United States)

Author keywords

Anal cancer; Definitive chemoradiation; Intensity modulated radiotherapy

Indexed keywords

FLUOROURACIL; MITOMYCIN;

ADULT; AGED; ANUS CARCINOMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONVENTIONAL RADIOTHERAPY; DISTANT METASTASIS FREE SURVIVAL; FEMALE; HUMAN; INDUCTION CHEMOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPENSITY SCORE; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

AGED; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPENSITY SCORE; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES;

EID: 84879016858     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.03.012     Document Type: Article

References (23)

1. UKCCCR Anal Cancer Trial Working Party UK Co-ordinating Committee on Cancer Research Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin Lancet 348 1996 1049 1054
2. J.A. Ajani, K.A. Winter, and L.L. Gunderson Fluorouracil, mitomycin, and radiotherapy vs. fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial JAMA 299 2008 1914 1921 (Pubitemid 351574921)
3. P.C. Austin The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studies Stat Med 29 2010 2137 2148
4. H. Bartelink, F. Roelofsen, and F. Eschwege Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups J Clin Oncol 15 1997 2040 2049 (Pubitemid 27209535)
5. E.C. Constantinou, W. Daly, C.Y. Fung, C.G. Willett, D.S. Kaufman, and T.F. DeLaney Time-dose considerations in the treatment of anal cancer Int J Radiat Oncol Biol Phys 39 1997 651 657 (Pubitemid 27441432)
6. P. Das, S. Bhatia, and C. Eng Predictors and patterns of recurrence after definitive chemoradiation for anal cancer Int J Radiat Oncol Biol Phys 68 2007 794 800 (Pubitemid 46818735)
7. P. Das, C.H. Crane, C. Eng, and J.A. Ajani Prognostic factors for squamous cell cancer of the anal canal Gastrointest Cancer Res 2 2008 10 14
8. F.L. Day, E. Link, and S. Ngan FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy Br J Cancer 105 2011 498 504
9. N. Dogan, L.B. Leybovich, S. King, A. Sethi, and B. Emami Improvement of treatment plans developed with intensity-modulated radiation therapy for concave-shaped head and neck tumors Radiology 223 2002 57 64 (Pubitemid 34258190)
10. M. Flam, M. John, and T.F. Pajak Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study J Clin Oncol 14 1996 2527 2539 (Pubitemid 26300120)
11. R.J. Glynn, S. Schneeweiss, and T. Sturmer Indications for propensity scores and review of their use in pharmacoepidemiology Basic Clin Pharmacol Toxicol 98 2006 253 259
12. K. Huang, D. Haas-Kogan, V. Weinberg, and R. Krieg Higher radiation dose with a shorter treatment duration improves outcome for locally advanced carcinoma of anal canal World J Gastroenterol 13 2007 895 900 (Pubitemid 46470300)
13. L.L. Hughes, T.A. Rich, L. Delclos, J.A. Ajani, and R.G. Martin Radiotherapy for anal cancer: experience from 1979-1987 Int J Radiat Oncol Biol Phys 17 1989 1153 1160 (Pubitemid 20028630)
14. M. John, T. Pajak, and M. Flam Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08 Cancer J Sci Am 2 1996 205 211
15. L.A. Kachnic, H.K. Tsai, and J.J. Coen Dose-painted Intensity-modulated Radiation Therapy for Anal Cancer: a multi-institutional report of acute toxicity and response to therapy Int J Radiat Oncol Biol Phys 2010
16. K. Khanfir, M. Ozsahin, S. Bieri, C. Cavuto, R.O. Mirimanoff, and A. Zouhair Patterns of failure and outcome in patients with carcinoma of the anal margin Ann Surg Oncol 15 2008 1092 1098
17. A. Konski, M. Garcia Jr., and M. John Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08 Int J Radiat Oncol Biol Phys 72 2008 114 118
18. M.T. Milano, A.B. Jani, K.J. Farrey, C. Rash, R. Heimann, and S.J. Chmura Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome Int J Radiat Oncol Biol Phys 63 2005 354 361 (Pubitemid 41317151)
19. P.R. Rosenbaum, and D.B. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1983 41 55
20. K. Saarilahti, P. Arponen, L. Vaalavirta, and M. Tenhunen The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer Radiother Oncol 87 2008 383 390
21. J.K. Salama, L.K. Mell, and D.A. Schomas Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience J Clin Oncol 25 2007 4581 4586 (Pubitemid 350035316)
22. K.G. Sunesen, M. Norgaard, and L. Lundby Cause-specific colostomy rates after radiotherapy for anal cancer: a Danish multicentre cohort study J Clin Oncol 29 2011 3535 3540
23. J.L. Wright, S.M. Patil, L.K. Temple, B.D. Minsky, L.B. Saltz, and K.A. Goodman Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning Int J Radiat Oncol Biol Phys 78 2010 1064 1072